ACPU
CELG

Arrowgrass Capital Partners (US)’s Celgene Corp CELG Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,100
Closed -$1.68M – 548
2017
Q4 		$1.68M Buy
16,100
+14,924
+1,269% +$1.68M 0.02% 405
2017
Q3 		$17.1M Hold
1,176
– – 0.13% 197
2017
Q2 		$15.3M Buy
1,176
+485
+70% +$59.4K 0.12% 226
2017
Q1 		$8.6M Sell
691
-214
-24% -$25.6K 0.09% 266
2016
Q4 		$10.5M Buy
905
+548
+154% +$61K 0.12% 174
2016
Q3 		$3.73M Buy
357
+225
+170% +$24.4K 0.05% 241
2016
Q2 		$1.3M Buy
+132
New +$13.7K 0.01% 315
2015
Q4 		– Sell
-37
Closed -$400K – 509
2015
Q3 		$400K Hold
37
– – 0.01% 404
2015
Q2 		$428K Buy
+37
New +$4.23K 0.01% 459

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s CELG Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 1,002,964 shares — an estimated $92.7M sold.

Arrowgrass Capital Partners (US) first reported a position in CELG in Q4 2013 and held it in 9 quarters. The position peaked at $92.7M in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 1,002,964 Celgene Corp shares in Q3 2019, an estimated $92.7M.
  • Arrowgrass Capital Partners (US) first reported a position in Celgene Corp in Q4 2013 and held it in 9 quarters.
  • Arrowgrass Capital Partners (US)'s Celgene Corp position peaked at $92.7M in Q2 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.